Rush MD Anderson Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Rush MD Anderson Cancer Center has participated in 103 clinical trials with 93 currently active.
Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Chicago
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush MD Anderson Cancer Center has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush MD Anderson Cancer Center has 103 clinical trials on record, with 93 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.
Rush MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.